Optimization of a Human Bacille Calmette-Guérin Challenge Model: A Tool to Evaluate Antimycobacterial Immunity

Por Minhinnick, Alice, Harris, Stephanie, Wilkie, Morven, Peter, Jonathan, Stockdale, Lisa, Manjaly-Thomas, Zita-Rose, Vermaak, Samantha, Satti, Iman, Moss, Paul, McShane, Helen
Publicado no J Infect Dis (2016)

The Candidate TB Vaccine, MVA85A, Induces Highly Durable Th1 Responses

Por Tameris, Michele, Geldenhuys, Hennie, Luabeya, Angelique KanyKany, Smit, Erica, Hughes, Jane E., Vermaak, Samantha, Hanekom, Willem A., Hatherill, Mark, Mahomed, Hassan, McShane, Helen, Scriba, Thomas J.
Publicado em 2014

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial

Por Wajja, Anne, Kizito, Dennison, Nassanga, Beatrice, Nalwoga, Angela, Kabagenyi, Joyce, Kimuda, Simon, Galiwango, Ronald, Mutonyi, Gertrude, Vermaak, Samantha, Satti, Iman, Verweij, Jaco, Tukahebwa, Edridah, Cose, Stephen, Levin, Jonathan, Kaleebu, Pontiano, Elliott, Alison M., McShane, Helen
Publicado no PLoS Negl Trop Dis (2017)

Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects

Por Dieye, Tandakha N., NDiaye, Birahim P., Dieng, Alle B., Fall, Marema, Britain, Nathaniel, Vermaak, Samantha, Camara, Makhtar, Diop-Ndiaye, Halimatou, Ngom-Gueye, Ndeye Fatou, Diaw, Papa A., Toure-Kane, Coumba, Sow, Papa S., Mboup, Souleymane, McShane, Helen
Publicado em 2013

Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects

Por Dieye, Tandakha N., NDiaye, Birahim P., Dieng, Alle B., Fall, Marema, Brittain, Nathaniel, Vermaak, Samantha, Camara, Makhtar, Diop-Ndiaye, Halimatou, Ngom-Gueye, Ndeye Fatou, Diaw, Papa A., Toure-Kane, Coumba, Sow, Papa S., Mboup, Souleymane, McShane, Helen
Publicado em 2013

A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults

Por Minhinnick, Alice, Satti, Iman, Harris, Stephanie, Wilkie, Morven, Sheehan, Sharon, Stockdale, Lisa, Thomas, Zita-Rose Manjaly, Lopez-Ramon, Raquel, Poulton, Ian, Lawrie, Alison, Vermaak, Samantha, Le Vert, Alexandre, Del Campo, Judith, Hill, Fergal, Moss, Paul, McShane, Helen
Publicado no Vaccine (2016)

A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated...

Por Sheehan, Sharon, Harris, Stephanie A., Satti, Iman, Hokey, David A., Dheenadhayalan, Veerabadran, Stockdale, Lisa, Manjaly Thomas, Zita-Rose, Minhinnick, Alice, Wilkie, Morven, Vermaak, Samantha, Meyer, Joel, O’Shea, Matthew K., Pau, Maria Grazia, Versteege, Isabella, Douoguih, Macaya, Hendriks, Jenny, Sadoff, Jerald, Landry, Bernard, Moss, Paul, McShane, Helen
Publicado no PLoS One (2015)